AUG 21, 2018 8:52 PM PDT

New Drug Delivery System for Precision Medicine

WRITTEN BY: Nouran Amin

A flexible drug delivery device providing controlled released offers the latest in personalized medicine. The device was developed by The Korea Advanced Institute of Science and Technology (KAIST) and offers a path to theragnosis.

An emerging medical technology, theragnosis, is receiving popularity as a key factor in advancing precision medicine by featuring simultaneous diagnosis and therapeutics. Theragnosis devices include smart contact lenses and microneedle patches that include physiological data sensors and drug delivery devices. The drug delivery systems are rooted for due to few side-effects, reliable therapeutic results, and minimal dosages in comparison to oral administration. In-human applications were recently conducted by some research groups for osteoporosis treatment research however, these applications have failed to demonstrate successful controlled release drug release through flexible drug delivery systems. Fortunately, for this microdevice, the research team guided under Professor Daesoo Kim from the Department of Biological Science and Professor Keon Jae Lee from the Department of Materials Science and Engineering created a device on a rigid substrate and transferred to an active drug delivery layer to the flexible substrate through an inorganic laser lift-off.

The developed device provided mechanical flexibility while maintaining the ability of precise administration for exact dosages at indicated times. The primary point of the device is to produce a gold cap layer that is directly placed on top of the microreservoir with the drugs inside; this had been seen as impossible in conventional microfabrication. Now, the drug delivery system can be applied to smart contact lenses or brain disease treatments by placing them into cramped and corrugated organs. Additionally, through wireless powering, the drug delivery device will represent a new platform for personalized medicine.

Experiments on animal models showed researchers that treating brain epilepsy was progressing well by releasing anti-epileptic medication through the drug delivery system. The team already proved through animal experimentation that treatment for brain epilepsy made progress by releasing anti-epileptic medication through the microdevice. This will further advance the applications of smart contact lenses, seeking effective therapeutic treatments for brain disease, and subcutaneous implantations during daily healthcare system use.

Source: Korea Advanced Institute of Science and Technology

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 02, 2020
Drug Discovery & Development
JAN 02, 2020
FDA Approves Ovarian Cancer Drug to Treat Pancreatic Cancer
In 2019, an estimated 46,000 Americans died from pancreatic cancer. Now, the Food and Drug Administration (FDA) has approved Lynparza, an ovarian cancer dr...
JAN 13, 2020
Drug Discovery & Development
JAN 13, 2020
Vaccine Against Alzheimer's to Hit Clinical Trials
Currently Alzheimer’s disease is thought to affect around 50 million people around the world, with this figure doubling every year. Currently with no...
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
Acid-Reflux Drugs May Negatively Impact Breast Cancer Survivors
Many of us have taken some form of an acid-reflux drug—especially after a meal that causes discomfort. However, now researchers are indicating that s...
FEB 04, 2020
Cancer
FEB 04, 2020
The role of SRR in colorectal cancer
Researchers from Osaka University have recently discovered a new function of the multifunctional enzyme entitled serine racemase (SRR). According to the te...
FEB 26, 2020
Microbiology
FEB 26, 2020
NIAID Tests Remdesivir as a Treatment for COVID-19
A case of coronavirus has now occured in the US in someone without a known link to an infected person or travel....
MAR 16, 2020
Drug Discovery & Development
MAR 16, 2020
Critical Interleukin Leads to Drug Discovery
The immune molecule interleukin-2 (IL-2) is a growth factor that stimulates the immune system to produce T-cells. Their powerful effects have encouraged re...
Loading Comments...